The Health Effects of Cannabis and Cannabinoids
The Health Effects of Cannabis and Cannabinoids

Author: National Academies of Sciences, Engineering, and Medicine

Publisher: National Academies Press

Published: 2017-03-31

Total Pages: 487

ISBN-13: 0309453070

DOWNLOAD EBOOK

Significant changes have taken place in the policy landscape surrounding cannabis legalization, production, and use. During the past 20 years, 25 states and the District of Columbia have legalized cannabis and/or cannabidiol (a component of cannabis) for medical conditions or retail sales at the state level and 4 states have legalized both the medical and recreational use of cannabis. These landmark changes in policy have impacted cannabis use patterns and perceived levels of risk. However, despite this changing landscape, evidence regarding the short- and long-term health effects of cannabis use remains elusive. While a myriad of studies have examined cannabis use in all its various forms, often these research conclusions are not appropriately synthesized, translated for, or communicated to policy makers, health care providers, state health officials, or other stakeholders who have been charged with influencing and enacting policies, procedures, and laws related to cannabis use. Unlike other controlled substances such as alcohol or tobacco, no accepted standards for safe use or appropriate dose are available to help guide individuals as they make choices regarding the issues of if, when, where, and how to use cannabis safely and, in regard to therapeutic uses, effectively. Shifting public sentiment, conflicting and impeded scientific research, and legislative battles have fueled the debate about what, if any, harms or benefits can be attributed to the use of cannabis or its derivatives, and this lack of aggregated knowledge has broad public health implications. The Health Effects of Cannabis and Cannabinoids provides a comprehensive review of scientific evidence related to the health effects and potential therapeutic benefits of cannabis. This report provides a research agendaâ€"outlining gaps in current knowledge and opportunities for providing additional insight into these issuesâ€"that summarizes and prioritizes pressing research needs.

Dioxin Perspectives
Dioxin Perspectives

Author: Erich W. Bretthauer

Publisher: Springer Science & Business Media

Published: 2012-12-06

Total Pages: 785

ISBN-13: 1461533082

DOWNLOAD EBOOK

Erich W. Bretthauer, Chairman of the Exposure and Hazard Assessment Working Group U. s. Environmental Protection Agency Washington, D. C. The efforts of the Exposure and Hazard Assessment Working Group were focused on the exchange of information on a variety of topics including research projects, regulations/statutes, analytical laboratories, and methods of exposure/risk assessment involving CDDs and CDFs. It was evident to the leaders of the Working Group that several of the knowledge voids had to be addressed on a fundamental level before expanded efforts could be made. Several questions needed to be answered: • Who has done research on this topic, and what do the data indicate? • Who is performing research now, and what are their capabilities? • How are other nations addressing this problem, and do they have legislative mandates in place? • Is there a general consensus on the topic? The members of the Working Group believed that these questions could be answered by surveying the major participants in the field of interest. Three principal survey efforts were performed by the Working Group, which collected information on research, regulations/statutes, and analytical laboratories from each of the participating nations. In addition to answering these fundamental questions, these efforts also fulfilled the major objectives of the entire Pilot Study. The collection, analysis, and distribution of information on research projects, regulations/statutes, and analytical laboratories were very useful efforts in helping to fill some of the basic knowledge voids.

Oil in the Sea III
Oil in the Sea III

Author: National Research Council

Publisher: National Academies Press

Published: 2003-03-14

Total Pages: 278

ISBN-13: 0309084385

DOWNLOAD EBOOK

Since the early 1970s, experts have recognized that petroleum pollutants were being discharged in marine waters worldwide, from oil spills, vessel operations, and land-based sources. Public attention to oil spills has forced improvements. Still, a considerable amount of oil is discharged yearly into sensitive coastal environments. Oil in the Sea provides the best available estimate of oil pollutant discharge into marine waters, including an evaluation of the methods for assessing petroleum load and a discussion about the concerns these loads represent. Featuring close-up looks at the Exxon Valdez spill and other notable events, the book identifies important research questions and makes recommendations for better analysis ofâ€"and more effective measures againstâ€"pollutant discharge. The book discusses: Inputâ€"where the discharges come from, including the role of two-stroke engines used on recreational craft. Behavior or fateâ€"how oil is affected by processes such as evaporation as it moves through the marine environment. Effectsâ€"what we know about the effects of petroleum hydrocarbons on marine organisms and ecosystems. Providing a needed update on a problem of international importance, this book will be of interest to energy policy makers, industry officials and managers, engineers and researchers, and advocates for the marine environment.

Acute Exposure Guideline Levels for Selected Airborne Chemicals
Acute Exposure Guideline Levels for Selected Airborne Chemicals

Author: National Research Council

Publisher: National Academies Press

Published: 2010-03-18

Total Pages: 465

ISBN-13: 030915233X

DOWNLOAD EBOOK

This book is the eighth volume in the series Acute Exposure Guideline Levels for Selected Airborne Chemicals, and reviews AEGLs for acrolein, carbon monoxide, 1,2-dichloroethene, ethylenimine, fluorine, hydrazine, peracetic acid, propylenimine, and sulfur dioxide for scientific accuracy, completeness, and consistency with the NRC guideline reports.

Analytical Chemistry of PCBs
Analytical Chemistry of PCBs

Author: Mitchell D. Erickson

Publisher: Routledge

Published: 2018-05-11

Total Pages: 688

ISBN-13: 1351466550

DOWNLOAD EBOOK

This updated and expanded Second Edition of Dr. Erickson's Analytical Chemistry of PCBs appears a decade after the first and is completely revised and updated. The changes from the First Edition reflect the significant growth in the area and a growing appreciation of the importance of PCB analysis to our culture. This book is a comprehensive review of the analytical chemistry of PCBs. It is part history, part annotated bibliography, part comparison, and part guidance. Featuring a new chapter on analyst/customer interactions and several new appendices, the Second Edition is an invaluable resource for both chemists with no experience in PCB analysis and seasoned PCB researchers. All topics have been more thoroughly treated and updated in this new edition to reflect advances made in the last decade, especially:

Pain Management and the Opioid Epidemic
Pain Management and the Opioid Epidemic

Author: National Academies of Sciences, Engineering, and Medicine

Publisher: National Academies Press

Published: 2017-09-28

Total Pages: 483

ISBN-13: 0309459575

DOWNLOAD EBOOK

Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.